MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020
Y

MD Anderson 2020 Updates on IO-Related GI Toxicity in Melanoma: What Are the OS Rates With Vedolizumab vs. Infliximab?

By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Yinghong (Mimi) Wong
By MD Anderson's The Art and Science of Managing the New Melanoma Landscape 2020 FEATURING Yinghong (Mimi) Wong
98 views
November 19, 2020
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update

2023 Updates on Dysplastic Nevi

Feat. B. Kelley
20:09
Melanoma 2024: 34th Annual Cutaneous Malignancy Update

Dysplastic Nevi: Navigating the Risk Landscape

Feat. B. Kelley
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
23:09
Total Health

Key Updates in Skin Melanoma

Feat. R. Seedor
06:39
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Analysis of Distant Metastasis-Free…

Feat. J. Luke
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
08:48
David Polsky

Promoting Skin Self-Exam for the Secondary Prevention of Melanoma

17:39
Melanoma Bridge 2023

Major Emerging Paradigm Shifts That Will Change Melanoma Management …

Feat. A. Eggermont
10:39
University of Colorado Department of Medicine

Cardio-Oncology: Definitions and Scope

Feat. L. Kondapalli
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
08:38
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 3 Trial Comparing Fianlimab + Cem…

Feat. T. Panella
19:52
OncoAlert

Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…

Feat. A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center

Pediatric Melanoma

Feat. M. Jen
21:12
Robert Swerlick

Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?

05:37
Melanoma Bridge 2023

COLUMBUS 7-Year Update: Encorafenib + Binimetinib vs. Vemurafenib or…

Feat. R. Dummer
52:19
Winship Melanoma and Cutaneous Oncology Symposium

2024 Updates on Neoadjuvant Therapy for Resectable Melanoma

Feat. S. Patel
08:46
Sapna Patel

Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…